Accelerate Cancer Research

The phenomenon, named 'nanomaterials induced endothelial leakiness' (NanoEL), accelerates the movement of cancer cells from the primary tumour and also causes circulating cancer cells to escape from blood circulation.

An energy sensing enzyme can potentially become a therapeutic target for future cancer drugs as it is responsible for sensing the available supply of GTP -- an energy source that fuels the uncontrolled growth of cancer cells, new research has found.

To accelerate cancer research, scientists have developed a "smart" robot that plans and conducts experiments with many substances and draws its own conclusions from the results.

The phenomenon, named 'nanomaterials induced endothelial leakiness' (NanoEL), accelerates the movement of cancer cells from the primary tumour and also causes circulating cancer cells to escape from blood circulation.

An energy sensing enzyme can potentially become a therapeutic target for future cancer drugs as it is responsible for sensing the available supply of GTP -- an energy source that fuels the uncontrolled growth of cancer cells, new research has found.

To accelerate cancer research, scientists have developed a "smart" robot that plans and conducts experiments with many substances and draws its own conclusions from the results.